循环miRNA特征：癌症预后的有前景的工具。 - Suppr

Suppr

超能文献

Circulating miRNA signatures: promising prognostic tools for cancer.

作者信息

Heneghan Helen M, Miller Nicola, Kerin Michael J

出版信息

J Clin Oncol. 2010 Oct 10;28(29):e573-4; author reply e575-6. doi: 10.1200/JCO.2010.29.8901. Epub 2010 Aug 9.

DOI:10.1200/JCO.2010.29.8901

PMID:20697097

Abstract

摘要

相似文献

Circulating miRNA signatures: promising prognostic tools for cancer.

J Clin Oncol. 2010 Oct 10;28(29):e573-4; author reply e575-6. doi: 10.1200/JCO.2010.29.8901. Epub 2010 Aug 9.

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

J Clin Oncol. 2010 Apr 1;28(10):1721-6. doi: 10.1200/JCO.2009.24.9342. Epub 2010 Mar 1.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

Cancer Res. 2009 Jul 15;69(14):5776-83. doi: 10.1158/0008-5472.CAN-09-0587. Epub 2009 Jul 7.

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Cancer J. 2012 May-Jun;18(3):268-74. doi: 10.1097/PPO.0b013e318258b743.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

First clinically useful marker for lung cancer identified.

Oncology (Williston Park). 2003 May;17(5):737-8.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):189-90; author reply 190-1. doi: 10.1056/NEJMc062409.

引用本文的文献

Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.

BMC Cancer. 2025 Apr 21;25(1):743. doi: 10.1186/s12885-025-14098-9.

A review of prognostic and predictive biomarkers in breast cancer.

Clin Exp Med. 2023 Feb;23(1):1-16. doi: 10.1007/s10238-021-00781-1. Epub 2022 Jan 15.

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.

Front Genet. 2021 Jun 7;12:666306. doi: 10.3389/fgene.2021.666306. eCollection 2021.

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer.

Cancer Cell Int. 2020 Nov 3;20(1):534. doi: 10.1186/s12935-020-01623-y.

miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma.

Oncol Lett. 2018 Aug;16(2):1666-1674. doi: 10.3892/ol.2018.8874. Epub 2018 Jun 1.

The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Mol Cancer Res. 2017 Jul;15(7):953-964. doi: 10.1158/1541-7786.MCR-16-0372. Epub 2017 Mar 8.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Int J Mol Sci. 2016 Apr 27;17(5):627. doi: 10.3390/ijms17050627.

Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.

PLoS One. 2015 Nov 6;10(11):e0142264. doi: 10.1371/journal.pone.0142264. eCollection 2015.

The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.

J Cell Mol Med. 2015 Oct;19(10):2307-23. doi: 10.1111/jcmm.12625. Epub 2015 Jun 27.

miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.

Springerplus. 2014 Oct 28;3:636. doi: 10.1186/2193-1801-3-636. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Circulating miRNA signatures: promising prognostic tools for cancer.

作者信息

Heneghan Helen M, Miller Nicola, Kerin Michael J

出版信息

J Clin Oncol. 2010 Oct 10;28(29):e573-4; author reply e575-6. doi: 10.1200/JCO.2010.29.8901. Epub 2010 Aug 9.

DOI:10.1200/JCO.2010.29.8901

PMID:20697097

Abstract

摘要

相似文献

Circulating miRNA signatures: promising prognostic tools for cancer.

J Clin Oncol. 2010 Oct 10;28(29):e573-4; author reply e575-6. doi: 10.1200/JCO.2010.29.8901. Epub 2010 Aug 9.

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

J Clin Oncol. 2010 Apr 1;28(10):1721-6. doi: 10.1200/JCO.2009.24.9342. Epub 2010 Mar 1.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

Cancer Res. 2009 Jul 15;69(14):5776-83. doi: 10.1158/0008-5472.CAN-09-0587. Epub 2009 Jul 7.

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Cancer J. 2012 May-Jun;18(3):268-74. doi: 10.1097/PPO.0b013e318258b743.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

First clinically useful marker for lung cancer identified.

Oncology (Williston Park). 2003 May;17(5):737-8.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):190; author reply 190-1.

Refining prognosis in non-small-cell lung cancer.

N Engl J Med. 2007 Jan 11;356(2):189-90; author reply 190-1. doi: 10.1056/NEJMc062409.

引用本文的文献

Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.

BMC Cancer. 2025 Apr 21;25(1):743. doi: 10.1186/s12885-025-14098-9.

A review of prognostic and predictive biomarkers in breast cancer.

Clin Exp Med. 2023 Feb;23(1):1-16. doi: 10.1007/s10238-021-00781-1. Epub 2022 Jan 15.

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.

Front Genet. 2021 Jun 7;12:666306. doi: 10.3389/fgene.2021.666306. eCollection 2021.

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer.

Cancer Cell Int. 2020 Nov 3;20(1):534. doi: 10.1186/s12935-020-01623-y.

miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma.

Oncol Lett. 2018 Aug;16(2):1666-1674. doi: 10.3892/ol.2018.8874. Epub 2018 Jun 1.

The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Mol Cancer Res. 2017 Jul;15(7):953-964. doi: 10.1158/1541-7786.MCR-16-0372. Epub 2017 Mar 8.

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.

Int J Mol Sci. 2016 Apr 27;17(5):627. doi: 10.3390/ijms17050627.

Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.

PLoS One. 2015 Nov 6;10(11):e0142264. doi: 10.1371/journal.pone.0142264. eCollection 2015.

The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.

J Cell Mol Med. 2015 Oct;19(10):2307-23. doi: 10.1111/jcmm.12625. Epub 2015 Jun 27.

miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.

Springerplus. 2014 Oct 28;3:636. doi: 10.1186/2193-1801-3-636. eCollection 2014.